Lifemd outlines Q4 2026 $60M-$64M revenue and $3M-$6M adjusted EBITDA amid shift away from paid media (NASDAQ:LFMD)
· seekingalpha.com
LifeMD (LFMD) Q2 2026 earnings call recap: revenue, revised guidance, CAC and GLP-1 pricing shift, margins, and Q3–Q4 EBITDA outlook—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...